Loughlin J, Quinn S, Rivero E, Norman H, Earnest DL, Wong J, Seeger JD. No evidence for association of tegaserod with suicide-related outcomes. Poster presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S154-5.
Garcia-Esteve L, Navarro P, Ascaso C, Aguado J, Torres A. Major depressive episode in postpartum: a preliminary prospective 1-year naturalistic follow-up. In: Colombus F, editors. New research on postpartum depression. New York: United States. Novs Science Publishers, Inc; 2007. p.85-104.
Rubino A, Roskell NS, Tennis P, Mines D, Weich S, Andrews E. Risk of suicide during venlafaxine and comparator antidepressants treatment. Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006; 15:S40-1.